nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Desloratadine—allergic rhinitis	0.128	0.303	CbGbCtD
Carfilzomib—ABCB1—Loratadine—allergic rhinitis	0.0733	0.174	CbGbCtD
Carfilzomib—ABCB1—Methylprednisolone—allergic rhinitis	0.067	0.159	CbGbCtD
Carfilzomib—ABCB1—Betamethasone—allergic rhinitis	0.0436	0.104	CbGbCtD
Carfilzomib—ABCB1—Prednisolone—allergic rhinitis	0.043	0.102	CbGbCtD
Carfilzomib—ABCB1—Hydrocortisone—allergic rhinitis	0.0408	0.0969	CbGbCtD
Carfilzomib—ABCB1—Dexamethasone—allergic rhinitis	0.0254	0.0603	CbGbCtD
Carfilzomib—PSMB10—respiratory system—allergic rhinitis	0.0172	0.111	CbGeAlD
Carfilzomib—PSMB10—lung—allergic rhinitis	0.00913	0.0589	CbGeAlD
Carfilzomib—PSMB8—bronchus—allergic rhinitis	0.00912	0.0588	CbGeAlD
Carfilzomib—PSMB1—respiratory system—allergic rhinitis	0.00855	0.0552	CbGeAlD
Carfilzomib—PSMB2—respiratory system—allergic rhinitis	0.00834	0.0538	CbGeAlD
Carfilzomib—PSMB8—trachea—allergic rhinitis	0.00819	0.0528	CbGeAlD
Carfilzomib—PSMB5—bronchus—allergic rhinitis	0.00805	0.0519	CbGeAlD
Carfilzomib—PSMB1—eye—allergic rhinitis	0.00781	0.0504	CbGeAlD
Carfilzomib—PSMB2—eye—allergic rhinitis	0.00762	0.0492	CbGeAlD
Carfilzomib—PSMB5—trachea—allergic rhinitis	0.00723	0.0466	CbGeAlD
Carfilzomib—PSMB1—bronchus—allergic rhinitis	0.00704	0.0454	CbGeAlD
Carfilzomib—PSMB2—bronchus—allergic rhinitis	0.00687	0.0443	CbGeAlD
Carfilzomib—PSMB1—skin of body—allergic rhinitis	0.0068	0.0438	CbGeAlD
Carfilzomib—PSMB2—skin of body—allergic rhinitis	0.00663	0.0428	CbGeAlD
Carfilzomib—PSMB1—trachea—allergic rhinitis	0.00632	0.0408	CbGeAlD
Carfilzomib—PSMB2—trachea—allergic rhinitis	0.00617	0.0398	CbGeAlD
Carfilzomib—PSMB8—lung—allergic rhinitis	0.00588	0.0379	CbGeAlD
Carfilzomib—PSMB5—lung—allergic rhinitis	0.00519	0.0335	CbGeAlD
Carfilzomib—PSMB1—lung—allergic rhinitis	0.00454	0.0293	CbGeAlD
Carfilzomib—PSMB2—lung—allergic rhinitis	0.00443	0.0286	CbGeAlD
Carfilzomib—PSMB10—Proteasome Degradation—HLA-G—allergic rhinitis	0.00342	0.0295	CbGpPWpGaD
Carfilzomib—PSMB9—Proteasome Degradation—HLA-G—allergic rhinitis	0.00341	0.0294	CbGpPWpGaD
Carfilzomib—PSMB10—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.00338	0.0292	CbGpPWpGaD
Carfilzomib—PSMB9—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.00336	0.029	CbGpPWpGaD
Carfilzomib—PSMB10—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.00279	0.0241	CbGpPWpGaD
Carfilzomib—PSMB9—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.00278	0.024	CbGpPWpGaD
Carfilzomib—PSMB2—Proteasome Degradation—HLA-G—allergic rhinitis	0.00259	0.0224	CbGpPWpGaD
Carfilzomib—PSMB1—Proteasome Degradation—HLA-G—allergic rhinitis	0.00259	0.0224	CbGpPWpGaD
Carfilzomib—PSMB5—Proteasome Degradation—HLA-G—allergic rhinitis	0.00259	0.0224	CbGpPWpGaD
Carfilzomib—PSMB2—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.00256	0.0221	CbGpPWpGaD
Carfilzomib—PSMB1—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.00256	0.0221	CbGpPWpGaD
Carfilzomib—PSMB5—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.00256	0.0221	CbGpPWpGaD
Carfilzomib—PSMB8—Proteasome Degradation—HLA-G—allergic rhinitis	0.00256	0.0221	CbGpPWpGaD
Carfilzomib—PSMB8—ER-Phagosome pathway—HLA-G—allergic rhinitis	0.00252	0.0218	CbGpPWpGaD
Carfilzomib—PSMB8—Interferon alpha/beta signaling—HLA-G—allergic rhinitis	0.00246	0.0213	CbGpPWpGaD
Carfilzomib—PSMB9—Type II interferon signaling (IFNG)—ICAM1—allergic rhinitis	0.00234	0.0202	CbGpPWpGaD
Carfilzomib—PSMB5—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.00211	0.0183	CbGpPWpGaD
Carfilzomib—PSMB1—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.00211	0.0183	CbGpPWpGaD
Carfilzomib—PSMB2—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.00211	0.0183	CbGpPWpGaD
Carfilzomib—PSMB8—Antigen processing-Cross presentation—HLA-G—allergic rhinitis	0.00208	0.018	CbGpPWpGaD
Carfilzomib—PSMB8—Metixene—Cyproheptadine—allergic rhinitis	0.00205	0.132	CbGdCrCtD
Carfilzomib—Decreased appetite—Cyproheptadine—allergic rhinitis	0.0016	0.00545	CcSEcCtD
Carfilzomib—Dyspnoea—Desloratadine—allergic rhinitis	0.00159	0.00544	CcSEcCtD
Carfilzomib—Fatigue—Cyproheptadine—allergic rhinitis	0.00158	0.00541	CcSEcCtD
Carfilzomib—Neuritis—Betamethasone—allergic rhinitis	0.00157	0.00537	CcSEcCtD
Carfilzomib—Neuritis—Dexamethasone—allergic rhinitis	0.00157	0.00537	CcSEcCtD
Carfilzomib—Constipation—Cyproheptadine—allergic rhinitis	0.00157	0.00537	CcSEcCtD
Carfilzomib—Decreased appetite—Desloratadine—allergic rhinitis	0.00155	0.0053	CcSEcCtD
Carfilzomib—Fatigue—Desloratadine—allergic rhinitis	0.00154	0.00526	CcSEcCtD
Carfilzomib—Infection—Olopatadine—allergic rhinitis	0.00152	0.00518	CcSEcCtD
Carfilzomib—Hypoaesthesia—Cetirizine—allergic rhinitis	0.00152	0.00518	CcSEcCtD
Carfilzomib—Oedema peripheral—Cetirizine—allergic rhinitis	0.0015	0.00513	CcSEcCtD
Carfilzomib—Hypoaesthesia—Flunisolide—allergic rhinitis	0.00149	0.00509	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Montelukast—allergic rhinitis	0.00148	0.00507	CcSEcCtD
Carfilzomib—Oedema peripheral—Flunisolide—allergic rhinitis	0.00148	0.00504	CcSEcCtD
Carfilzomib—Thrombocytopenia—Dimenhydrinate—allergic rhinitis	0.00146	0.005	CcSEcCtD
Carfilzomib—Thrombocytopenia—Diphenhydramine—allergic rhinitis	0.00146	0.005	CcSEcCtD
Carfilzomib—Pneumonia—Montelukast—allergic rhinitis	0.00143	0.00489	CcSEcCtD
Carfilzomib—Anorexia—Diphenhydramine—allergic rhinitis	0.00142	0.00486	CcSEcCtD
Carfilzomib—Anorexia—Dimenhydrinate—allergic rhinitis	0.00142	0.00486	CcSEcCtD
Carfilzomib—Cardiac disorder—Cetirizine—allergic rhinitis	0.00141	0.00483	CcSEcCtD
Carfilzomib—Body temperature increased—Desloratadine—allergic rhinitis	0.00141	0.00482	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Montelukast—allergic rhinitis	0.0014	0.00477	CcSEcCtD
Carfilzomib—Chills—Cetirizine—allergic rhinitis	0.00137	0.00467	CcSEcCtD
Carfilzomib—Dyspnoea—Olopatadine—allergic rhinitis	0.00136	0.00465	CcSEcCtD
Carfilzomib—PSMB10—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.00136	0.0117	CbGpPWpGaD
Carfilzomib—PSMB9—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.00135	0.0117	CbGpPWpGaD
Carfilzomib—Insomnia—Diphenhydramine—allergic rhinitis	0.00135	0.00462	CcSEcCtD
Carfilzomib—Insomnia—Dimenhydrinate—allergic rhinitis	0.00135	0.00462	CcSEcCtD
Carfilzomib—Chills—Flunisolide—allergic rhinitis	0.00134	0.00459	CcSEcCtD
Carfilzomib—Asthenia—Cyproheptadine—allergic rhinitis	0.00132	0.0045	CcSEcCtD
Carfilzomib—Fatigue—Olopatadine—allergic rhinitis	0.00132	0.0045	CcSEcCtD
Carfilzomib—Pain—Olopatadine—allergic rhinitis	0.00131	0.00446	CcSEcCtD
Carfilzomib—Decreased appetite—Dimenhydrinate—allergic rhinitis	0.0013	0.00444	CcSEcCtD
Carfilzomib—Decreased appetite—Diphenhydramine—allergic rhinitis	0.0013	0.00444	CcSEcCtD
Carfilzomib—Fatigue—Dimenhydrinate—allergic rhinitis	0.00129	0.0044	CcSEcCtD
Carfilzomib—Fatigue—Diphenhydramine—allergic rhinitis	0.00129	0.0044	CcSEcCtD
Carfilzomib—Back pain—Cetirizine—allergic rhinitis	0.00128	0.00438	CcSEcCtD
Carfilzomib—Asthenia—Desloratadine—allergic rhinitis	0.00128	0.00438	CcSEcCtD
Carfilzomib—Constipation—Diphenhydramine—allergic rhinitis	0.00128	0.00436	CcSEcCtD
Carfilzomib—Constipation—Dimenhydrinate—allergic rhinitis	0.00128	0.00436	CcSEcCtD
Carfilzomib—Muscle spasms—Cetirizine—allergic rhinitis	0.00128	0.00436	CcSEcCtD
Carfilzomib—ABCB1—respiratory system—allergic rhinitis	0.00127	0.00822	CbGeAlD
Carfilzomib—Hypoaesthesia—Montelukast—allergic rhinitis	0.00127	0.00434	CcSEcCtD
Carfilzomib—Back pain—Flunisolide—allergic rhinitis	0.00126	0.00431	CcSEcCtD
Carfilzomib—Diarrhoea—Cyproheptadine—allergic rhinitis	0.00126	0.00429	CcSEcCtD
Carfilzomib—Cough—Loratadine—allergic rhinitis	0.00123	0.0042	CcSEcCtD
Carfilzomib—Diarrhoea—Desloratadine—allergic rhinitis	0.00122	0.00417	CcSEcCtD
Carfilzomib—Hypertension—Loratadine—allergic rhinitis	0.00122	0.00416	CcSEcCtD
Carfilzomib—Dizziness—Cyproheptadine—allergic rhinitis	0.00121	0.00415	CcSEcCtD
Carfilzomib—Body temperature increased—Olopatadine—allergic rhinitis	0.00121	0.00412	CcSEcCtD
Carfilzomib—Cardiac disorder—Montelukast—allergic rhinitis	0.00119	0.00405	CcSEcCtD
Carfilzomib—Dizziness—Desloratadine—allergic rhinitis	0.00118	0.00403	CcSEcCtD
Carfilzomib—Vomiting—Cyproheptadine—allergic rhinitis	0.00117	0.00399	CcSEcCtD
Carfilzomib—Cough—Cetirizine—allergic rhinitis	0.00116	0.00395	CcSEcCtD
Carfilzomib—Headache—Cyproheptadine—allergic rhinitis	0.00115	0.00393	CcSEcCtD
Carfilzomib—PSMB8—Interferon Signaling—HLA-G—allergic rhinitis	0.00115	0.0099	CbGpPWpGaD
Carfilzomib—Hypertension—Cetirizine—allergic rhinitis	0.00115	0.00391	CcSEcCtD
Carfilzomib—Cough—Flunisolide—allergic rhinitis	0.00114	0.00389	CcSEcCtD
Carfilzomib—Vomiting—Desloratadine—allergic rhinitis	0.00114	0.00388	CcSEcCtD
Carfilzomib—Arthralgia—Cetirizine—allergic rhinitis	0.00113	0.00386	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisolone—allergic rhinitis	0.00113	0.00385	CcSEcCtD
Carfilzomib—Hypertension—Flunisolide—allergic rhinitis	0.00113	0.00385	CcSEcCtD
Carfilzomib—Headache—Desloratadine—allergic rhinitis	0.00112	0.00382	CcSEcCtD
Carfilzomib—PSMB10—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.00111	0.00962	CbGpPWpGaD
Carfilzomib—PSMB9—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.00111	0.00957	CbGpPWpGaD
Carfilzomib—Cardiac failure congestive—Hydrocortisone—allergic rhinitis	0.0011	0.00376	CcSEcCtD
Carfilzomib—Asthenia—Olopatadine—allergic rhinitis	0.0011	0.00374	CcSEcCtD
Carfilzomib—Nausea—Cyproheptadine—allergic rhinitis	0.00109	0.00373	CcSEcCtD
Carfilzomib—Infection—Cetirizine—allergic rhinitis	0.00108	0.00367	CcSEcCtD
Carfilzomib—Asthenia—Dimenhydrinate—allergic rhinitis	0.00107	0.00366	CcSEcCtD
Carfilzomib—Asthenia—Diphenhydramine—allergic rhinitis	0.00107	0.00366	CcSEcCtD
Carfilzomib—Muscle spasms—Montelukast—allergic rhinitis	0.00107	0.00365	CcSEcCtD
Carfilzomib—ABCB1—epithelium—allergic rhinitis	0.00107	0.00687	CbGeAlD
Carfilzomib—Nausea—Desloratadine—allergic rhinitis	0.00106	0.00362	CcSEcCtD
Carfilzomib—Thrombocytopenia—Cetirizine—allergic rhinitis	0.00106	0.00362	CcSEcCtD
Carfilzomib—Infection—Flunisolide—allergic rhinitis	0.00106	0.00361	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Loratadine—allergic rhinitis	0.00105	0.00358	CcSEcCtD
Carfilzomib—Diarrhoea—Olopatadine—allergic rhinitis	0.00104	0.00357	CcSEcCtD
Carfilzomib—Insomnia—Loratadine—allergic rhinitis	0.00104	0.00355	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Triamcinolone—allergic rhinitis	0.00104	0.00354	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Methylprednisolone—allergic rhinitis	0.00103	0.00353	CcSEcCtD
Carfilzomib—Anorexia—Cetirizine—allergic rhinitis	0.00103	0.00352	CcSEcCtD
Carfilzomib—PSMB1—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.00103	0.0089	CbGpPWpGaD
Carfilzomib—PSMB5—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.00103	0.0089	CbGpPWpGaD
Carfilzomib—PSMB2—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.00103	0.0089	CbGpPWpGaD
Carfilzomib—Diarrhoea—Diphenhydramine—allergic rhinitis	0.00102	0.00349	CcSEcCtD
Carfilzomib—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.00102	0.00349	CcSEcCtD
Carfilzomib—PSMB8—Vpu mediated degradation of CD4—CD4—allergic rhinitis	0.00102	0.00877	CbGpPWpGaD
Carfilzomib—Dizziness—Olopatadine—allergic rhinitis	0.00101	0.00345	CcSEcCtD
Carfilzomib—Fatigue—Loratadine—allergic rhinitis	0.000992	0.00339	CcSEcCtD
Carfilzomib—Dizziness—Diphenhydramine—allergic rhinitis	0.000988	0.00337	CcSEcCtD
Carfilzomib—Dizziness—Dimenhydrinate—allergic rhinitis	0.000988	0.00337	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Cetirizine—allergic rhinitis	0.000986	0.00337	CcSEcCtD
Carfilzomib—Constipation—Loratadine—allergic rhinitis	0.000984	0.00336	CcSEcCtD
Carfilzomib—Pain—Loratadine—allergic rhinitis	0.000984	0.00336	CcSEcCtD
Carfilzomib—Insomnia—Cetirizine—allergic rhinitis	0.000979	0.00334	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisolone—allergic rhinitis	0.000971	0.00332	CcSEcCtD
Carfilzomib—Cough—Montelukast—allergic rhinitis	0.000971	0.00332	CcSEcCtD
Carfilzomib—Vomiting—Olopatadine—allergic rhinitis	0.000971	0.00332	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Flunisolide—allergic rhinitis	0.00097	0.00331	CcSEcCtD
Carfilzomib—Dyspnoea—Cetirizine—allergic rhinitis	0.000965	0.0033	CcSEcCtD
Carfilzomib—Insomnia—Flunisolide—allergic rhinitis	0.000963	0.00329	CcSEcCtD
Carfilzomib—Headache—Olopatadine—allergic rhinitis	0.000956	0.00327	CcSEcCtD
Carfilzomib—PSMB10—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.00095	0.0082	CbGpPWpGaD
Carfilzomib—Vomiting—Diphenhydramine—allergic rhinitis	0.00095	0.00324	CcSEcCtD
Carfilzomib—Vomiting—Dimenhydrinate—allergic rhinitis	0.00095	0.00324	CcSEcCtD
Carfilzomib—Dyspnoea—Flunisolide—allergic rhinitis	0.000949	0.00324	CcSEcCtD
Carfilzomib—Cardiac arrest—Hydrocortisone—allergic rhinitis	0.000948	0.00324	CcSEcCtD
Carfilzomib—Arthralgia—Montelukast—allergic rhinitis	0.000947	0.00323	CcSEcCtD
Carfilzomib—PSMB9—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.000946	0.00816	CbGpPWpGaD
Carfilzomib—ABCB1—trachea—allergic rhinitis	0.000942	0.00608	CbGeAlD
Carfilzomib—Decreased appetite—Cetirizine—allergic rhinitis	0.000941	0.00321	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Flunisolide—allergic rhinitis	0.00094	0.0603	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Flunisolide—allergic rhinitis	0.00094	0.0603	CbGdCrCtD
Carfilzomib—Cardiac failure congestive—Betamethasone—allergic rhinitis	0.00094	0.00321	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Dexamethasone—allergic rhinitis	0.00094	0.00321	CcSEcCtD
Carfilzomib—Headache—Diphenhydramine—allergic rhinitis	0.000936	0.0032	CcSEcCtD
Carfilzomib—Headache—Dimenhydrinate—allergic rhinitis	0.000936	0.0032	CcSEcCtD
Carfilzomib—Fatigue—Cetirizine—allergic rhinitis	0.000933	0.00319	CcSEcCtD
Carfilzomib—Constipation—Cetirizine—allergic rhinitis	0.000926	0.00316	CcSEcCtD
Carfilzomib—Pain—Cetirizine—allergic rhinitis	0.000926	0.00316	CcSEcCtD
Carfilzomib—Decreased appetite—Flunisolide—allergic rhinitis	0.000925	0.00316	CcSEcCtD
Carfilzomib—Fatigue—Flunisolide—allergic rhinitis	0.000918	0.00313	CcSEcCtD
Carfilzomib—Pain—Flunisolide—allergic rhinitis	0.00091	0.00311	CcSEcCtD
Carfilzomib—Constipation—Flunisolide—allergic rhinitis	0.00091	0.00311	CcSEcCtD
Carfilzomib—Body temperature increased—Loratadine—allergic rhinitis	0.00091	0.00311	CcSEcCtD
Carfilzomib—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.000908	0.0031	CcSEcCtD
Carfilzomib—Nausea—Olopatadine—allergic rhinitis	0.000907	0.0031	CcSEcCtD
Carfilzomib—Infection—Montelukast—allergic rhinitis	0.000902	0.00308	CcSEcCtD
Carfilzomib—Cardiac arrest—Triamcinolone—allergic rhinitis	0.000893	0.00305	CcSEcCtD
Carfilzomib—Cardiac arrest—Methylprednisolone—allergic rhinitis	0.000891	0.00304	CcSEcCtD
Carfilzomib—Thrombocytopenia—Montelukast—allergic rhinitis	0.000889	0.00304	CcSEcCtD
Carfilzomib—Nausea—Dimenhydrinate—allergic rhinitis	0.000887	0.00303	CcSEcCtD
Carfilzomib—Nausea—Diphenhydramine—allergic rhinitis	0.000887	0.00303	CcSEcCtD
Carfilzomib—Body temperature increased—Cetirizine—allergic rhinitis	0.000856	0.00292	CcSEcCtD
Carfilzomib—PSMB5—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000845	0.00729	CbGpPWpGaD
Carfilzomib—PSMB1—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000845	0.00729	CbGpPWpGaD
Carfilzomib—PSMB2—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000845	0.00729	CbGpPWpGaD
Carfilzomib—Body temperature increased—Flunisolide—allergic rhinitis	0.000841	0.00287	CcSEcCtD
Carfilzomib—PSMB8—Class I MHC mediated antigen processing & presentation—HLA-G—allergic rhinitis	0.000833	0.00719	CbGpPWpGaD
Carfilzomib—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.000827	0.00283	CcSEcCtD
Carfilzomib—Asthenia—Loratadine—allergic rhinitis	0.000826	0.00282	CcSEcCtD
Carfilzomib—Insomnia—Montelukast—allergic rhinitis	0.000821	0.0028	CcSEcCtD
Carfilzomib—Cardiac arrest—Dexamethasone—allergic rhinitis	0.00081	0.00277	CcSEcCtD
Carfilzomib—Cardiac arrest—Betamethasone—allergic rhinitis	0.00081	0.00277	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Hydrocortisone—allergic rhinitis	0.000801	0.00274	CcSEcCtD
Carfilzomib—Diarrhoea—Loratadine—allergic rhinitis	0.000787	0.00269	CcSEcCtD
Carfilzomib—Fatigue—Montelukast—allergic rhinitis	0.000783	0.00267	CcSEcCtD
Carfilzomib—Asthenia—Cetirizine—allergic rhinitis	0.000777	0.00265	CcSEcCtD
Carfilzomib—Pain—Montelukast—allergic rhinitis	0.000776	0.00265	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisolone—allergic rhinitis	0.000776	0.00265	CcSEcCtD
Carfilzomib—Hypokalaemia—Betamethasone—allergic rhinitis	0.000776	0.00265	CcSEcCtD
Carfilzomib—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000776	0.00265	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisolone—allergic rhinitis	0.000771	0.00264	CcSEcCtD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000765	0.00661	CbGpPWpGaD
Carfilzomib—Asthenia—Flunisolide—allergic rhinitis	0.000764	0.00261	CcSEcCtD
Carfilzomib—Dizziness—Loratadine—allergic rhinitis	0.000761	0.0026	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Hydrocortisone—allergic rhinitis	0.000758	0.00259	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Triamcinolone—allergic rhinitis	0.000754	0.00258	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Hydrocortisone—allergic rhinitis	0.000753	0.00257	CcSEcCtD
Carfilzomib—Diarrhoea—Cetirizine—allergic rhinitis	0.000741	0.00253	CcSEcCtD
Carfilzomib—Vomiting—Loratadine—allergic rhinitis	0.000732	0.0025	CcSEcCtD
Carfilzomib—Diarrhoea—Flunisolide—allergic rhinitis	0.000728	0.00249	CcSEcCtD
Carfilzomib—Headache—Loratadine—allergic rhinitis	0.000721	0.00246	CcSEcCtD
Carfilzomib—PSMB1—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.00072	0.00622	CbGpPWpGaD
Carfilzomib—PSMB5—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.00072	0.00622	CbGpPWpGaD
Carfilzomib—PSMB2—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.00072	0.00622	CbGpPWpGaD
Carfilzomib—Body temperature increased—Montelukast—allergic rhinitis	0.000718	0.00245	CcSEcCtD
Carfilzomib—Dizziness—Cetirizine—allergic rhinitis	0.000716	0.00245	CcSEcCtD
Carfilzomib—PSMB8—Interferon Signaling—HLA-DQB1—allergic rhinitis	0.000715	0.00618	CbGpPWpGaD
Carfilzomib—Acute coronary syndrome—Triamcinolone—allergic rhinitis	0.000713	0.00244	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Methylprednisolone—allergic rhinitis	0.000712	0.00243	CcSEcCtD
Carfilzomib—PSMB8—Activation of NF-kappaB in B cells—NFKB1—allergic rhinitis	0.00071	0.00613	CbGpPWpGaD
Carfilzomib—Neuropathy peripheral—Triamcinolone—allergic rhinitis	0.000709	0.00242	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Methylprednisolone—allergic rhinitis	0.000708	0.00242	CcSEcCtD
Carfilzomib—PSMB10—Tamoxifen—Diphenhydramine—allergic rhinitis	0.000705	0.0452	CbGdCrCtD
Carfilzomib—Dizziness—Flunisolide—allergic rhinitis	0.000704	0.0024	CcSEcCtD
Carfilzomib—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	0.000692	0.00597	CbGpPWpGaD
Carfilzomib—Vomiting—Cetirizine—allergic rhinitis	0.000688	0.00235	CcSEcCtD
Carfilzomib—Nausea—Loratadine—allergic rhinitis	0.000683	0.00233	CcSEcCtD
Carfilzomib—Headache—Cetirizine—allergic rhinitis	0.000678	0.00232	CcSEcCtD
Carfilzomib—ABCB1—lung—allergic rhinitis	0.000677	0.00437	CbGeAlD
Carfilzomib—Vomiting—Flunisolide—allergic rhinitis	0.000677	0.00231	CcSEcCtD
Carfilzomib—Headache—Flunisolide—allergic rhinitis	0.000667	0.00228	CcSEcCtD
Carfilzomib—Hyperglycaemia—Betamethasone—allergic rhinitis	0.000664	0.00227	CcSEcCtD
Carfilzomib—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.000664	0.00227	CcSEcCtD
Carfilzomib—Asthenia—Montelukast—allergic rhinitis	0.000651	0.00222	CcSEcCtD
Carfilzomib—PSMB10—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000649	0.00561	CbGpPWpGaD
Carfilzomib—Acute coronary syndrome—Betamethasone—allergic rhinitis	0.000647	0.00221	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Dexamethasone—allergic rhinitis	0.000647	0.00221	CcSEcCtD
Carfilzomib—PSMB9—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000646	0.00558	CbGpPWpGaD
Carfilzomib—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000644	0.0022	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000644	0.0022	CcSEcCtD
Carfilzomib—Nausea—Cetirizine—allergic rhinitis	0.000643	0.0022	CcSEcCtD
Carfilzomib—Nausea—Flunisolide—allergic rhinitis	0.000632	0.00216	CcSEcCtD
Carfilzomib—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	0.000628	0.00543	CbGpPWpGaD
Carfilzomib—Diarrhoea—Montelukast—allergic rhinitis	0.000621	0.00212	CcSEcCtD
Carfilzomib—PSMB10—Immune System—MS4A2—allergic rhinitis	0.00062	0.00535	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000617	0.00533	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—MS4A2—allergic rhinitis	0.000617	0.00532	CbGpPWpGaD
Carfilzomib—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000602	0.00206	CcSEcCtD
Carfilzomib—Dizziness—Montelukast—allergic rhinitis	0.0006	0.00205	CcSEcCtD
Carfilzomib—ABCB1—Allograft Rejection—IL13—allergic rhinitis	0.000592	0.00511	CbGpPWpGaD
Carfilzomib—Vomiting—Montelukast—allergic rhinitis	0.000577	0.00197	CcSEcCtD
Carfilzomib—Headache—Montelukast—allergic rhinitis	0.000569	0.00194	CcSEcCtD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-G—allergic rhinitis	0.000552	0.00476	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-G—allergic rhinitis	0.000549	0.00474	CbGpPWpGaD
Carfilzomib—Back pain—Triamcinolone—allergic rhinitis	0.000547	0.00187	CcSEcCtD
Carfilzomib—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	0.000545	0.0047	CbGpPWpGaD
Carfilzomib—Nausea—Montelukast—allergic rhinitis	0.000539	0.00184	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Flunisolide—allergic rhinitis	0.000532	0.0341	CbGdCrCtD
Carfilzomib—Hypertension—Prednisolone—allergic rhinitis	0.000531	0.00181	CcSEcCtD
Carfilzomib—PSMB8—Interferon Signaling—ICAM1—allergic rhinitis	0.000522	0.00451	CbGpPWpGaD
Carfilzomib—Hypertension—Hydrocortisone—allergic rhinitis	0.000519	0.00177	CcSEcCtD
Carfilzomib—ABCB1—Allograft Rejection—IL5—allergic rhinitis	0.000507	0.00437	CbGpPWpGaD
Carfilzomib—Cough—Triamcinolone—allergic rhinitis	0.000494	0.00169	CcSEcCtD
Carfilzomib—PSMB5—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000492	0.00425	CbGpPWpGaD
Carfilzomib—PSMB1—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000492	0.00425	CbGpPWpGaD
Carfilzomib—PSMB2—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000492	0.00425	CbGpPWpGaD
Carfilzomib—Hypertension—Triamcinolone—allergic rhinitis	0.000488	0.00167	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Hydrocortisone—allergic rhinitis	0.000488	0.0313	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Hydrocortisone—allergic rhinitis	0.000488	0.0313	CbGdCrCtD
Carfilzomib—Hypertension—Methylprednisolone—allergic rhinitis	0.000487	0.00166	CcSEcCtD
Carfilzomib—Infection—Hydrocortisone—allergic rhinitis	0.000487	0.00166	CcSEcCtD
Carfilzomib—PSMB8—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000485	0.00419	CbGpPWpGaD
Carfilzomib—Arthralgia—Methylprednisolone—allergic rhinitis	0.00048	0.00164	CcSEcCtD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000478	0.00412	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—MS4A2—allergic rhinitis	0.00047	0.00405	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—MS4A2—allergic rhinitis	0.00047	0.00405	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—MS4A2—allergic rhinitis	0.00047	0.00405	CbGpPWpGaD
Carfilzomib—Anorexia—Hydrocortisone—allergic rhinitis	0.000467	0.0016	CcSEcCtD
Carfilzomib—PSMB8—Immune System—MS4A2—allergic rhinitis	0.000463	0.004	CbGpPWpGaD
Carfilzomib—PSMB9—Betamethasone—Methylprednisolone—allergic rhinitis	0.00046	0.0295	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Methylprednisolone—allergic rhinitis	0.00046	0.0295	CbGdCrCtD
Carfilzomib—Infection—Triamcinolone—allergic rhinitis	0.000459	0.00157	CcSEcCtD
Carfilzomib—Infection—Methylprednisolone—allergic rhinitis	0.000458	0.00156	CcSEcCtD
Carfilzomib—Insomnia—Prednisolone—allergic rhinitis	0.000454	0.00155	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Betamethasone—allergic rhinitis	0.000453	0.029	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Dexamethasone—allergic rhinitis	0.000453	0.029	CbGdCrCtD
Carfilzomib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000447	0.00153	CcSEcCtD
Carfilzomib—PSMB10—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000447	0.00386	CbGpPWpGaD
Carfilzomib—PSMB9—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000444	0.00384	CbGpPWpGaD
Carfilzomib—Insomnia—Hydrocortisone—allergic rhinitis	0.000443	0.00151	CcSEcCtD
Carfilzomib—Hypertension—Dexamethasone—allergic rhinitis	0.000443	0.00151	CcSEcCtD
Carfilzomib—Hypertension—Betamethasone—allergic rhinitis	0.000443	0.00151	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Triamcinolone—allergic rhinitis	0.000443	0.0284	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Triamcinolone—allergic rhinitis	0.000443	0.0284	CbGdCrCtD
Carfilzomib—Pain—Prednisolone—allergic rhinitis	0.000429	0.00147	CcSEcCtD
Carfilzomib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000426	0.00146	CcSEcCtD
Carfilzomib—Fatigue—Hydrocortisone—allergic rhinitis	0.000423	0.00144	CcSEcCtD
Carfilzomib—PSMB10—HIV Infection—CD4—allergic rhinitis	0.000422	0.00364	CbGpPWpGaD
Carfilzomib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000421	0.00144	CcSEcCtD
Carfilzomib—PSMB9—HIV Infection—CD4—allergic rhinitis	0.00042	0.00363	CbGpPWpGaD
Carfilzomib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.00042	0.00143	CcSEcCtD
Carfilzomib—Pain—Hydrocortisone—allergic rhinitis	0.000419	0.00143	CcSEcCtD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-G—allergic rhinitis	0.000418	0.00361	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-G—allergic rhinitis	0.000418	0.00361	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-G—allergic rhinitis	0.000418	0.00361	CbGpPWpGaD
Carfilzomib—Insomnia—Triamcinolone—allergic rhinitis	0.000418	0.00143	CcSEcCtD
Carfilzomib—Insomnia—Methylprednisolone—allergic rhinitis	0.000417	0.00142	CcSEcCtD
Carfilzomib—Infection—Betamethasone—allergic rhinitis	0.000416	0.00142	CcSEcCtD
Carfilzomib—Infection—Dexamethasone—allergic rhinitis	0.000416	0.00142	CcSEcCtD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-G—allergic rhinitis	0.000412	0.00356	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000412	0.00355	CbGpPWpGaD
Carfilzomib—Dyspnoea—Triamcinolone—allergic rhinitis	0.000412	0.00141	CcSEcCtD
Carfilzomib—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.00041	0.0014	CcSEcCtD
Carfilzomib—Thrombocytopenia—Betamethasone—allergic rhinitis	0.00041	0.0014	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Prednisolone—allergic rhinitis	0.00041	0.0263	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisolone—allergic rhinitis	0.00041	0.0263	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Flunisolide—allergic rhinitis	0.000405	0.026	CbGdCrCtD
Carfilzomib—Anorexia—Betamethasone—allergic rhinitis	0.000399	0.00136	CcSEcCtD
Carfilzomib—Anorexia—Dexamethasone—allergic rhinitis	0.000399	0.00136	CcSEcCtD
Carfilzomib—Fatigue—Triamcinolone—allergic rhinitis	0.000398	0.00136	CcSEcCtD
Carfilzomib—Fatigue—Methylprednisolone—allergic rhinitis	0.000397	0.00136	CcSEcCtD
Carfilzomib—Pain—Triamcinolone—allergic rhinitis	0.000395	0.00135	CcSEcCtD
Carfilzomib—PSMB10—B Cell Activation—NFKB1—allergic rhinitis	0.000395	0.00341	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—NFKB1—allergic rhinitis	0.000393	0.00339	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000392	0.00339	CbGpPWpGaD
Carfilzomib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000388	0.00132	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000382	0.0013	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000382	0.0013	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Hydrocortisone—allergic rhinitis	0.000381	0.0244	CbGdCrCtD
Carfilzomib—Insomnia—Betamethasone—allergic rhinitis	0.000379	0.00129	CcSEcCtD
Carfilzomib—Insomnia—Dexamethasone—allergic rhinitis	0.000379	0.00129	CcSEcCtD
Carfilzomib—ABCB1—Allograft Rejection—IL10—allergic rhinitis	0.00037	0.0032	CbGpPWpGaD
Carfilzomib—Body temperature increased—Triamcinolone—allergic rhinitis	0.000365	0.00125	CcSEcCtD
Carfilzomib—Decreased appetite—Betamethasone—allergic rhinitis	0.000364	0.00124	CcSEcCtD
Carfilzomib—Decreased appetite—Dexamethasone—allergic rhinitis	0.000364	0.00124	CcSEcCtD
Carfilzomib—Fatigue—Dexamethasone—allergic rhinitis	0.000361	0.00123	CcSEcCtD
Carfilzomib—Fatigue—Betamethasone—allergic rhinitis	0.000361	0.00123	CcSEcCtD
Carfilzomib—ABCB1—Allograft Rejection—IL4—allergic rhinitis	0.00036	0.00311	CbGpPWpGaD
Carfilzomib—PSMB8—Medrysone—Methylprednisolone—allergic rhinitis	0.000359	0.023	CbGdCrCtD
Carfilzomib—Pain—Betamethasone—allergic rhinitis	0.000358	0.00122	CcSEcCtD
Carfilzomib—Pain—Dexamethasone—allergic rhinitis	0.000358	0.00122	CcSEcCtD
Carfilzomib—Asthenia—Hydrocortisone—allergic rhinitis	0.000352	0.0012	CcSEcCtD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000349	0.00301	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000344	0.00297	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000343	0.00296	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PTGDR2—allergic rhinitis	0.000341	0.00294	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PTGDR2—allergic rhinitis	0.000339	0.00293	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000338	0.00292	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000338	0.00292	CbGpPWpGaD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000338	0.00292	CbGpPWpGaD
Carfilzomib—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000335	0.00115	CcSEcCtD
Carfilzomib—PSMB10—Immune System—HLA-G—allergic rhinitis	0.000335	0.00289	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000334	0.00288	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-G—allergic rhinitis	0.000333	0.00287	CbGpPWpGaD
Carfilzomib—Dizziness—Prednisolone—allergic rhinitis	0.000332	0.00113	CcSEcCtD
Carfilzomib—Asthenia—Triamcinolone—allergic rhinitis	0.000331	0.00113	CcSEcCtD
Carfilzomib—Body temperature increased—Betamethasone—allergic rhinitis	0.000331	0.00113	CcSEcCtD
Carfilzomib—Body temperature increased—Dexamethasone—allergic rhinitis	0.000331	0.00113	CcSEcCtD
Carfilzomib—Asthenia—Methylprednisolone—allergic rhinitis	0.00033	0.00113	CcSEcCtD
Carfilzomib—Dizziness—Hydrocortisone—allergic rhinitis	0.000324	0.00111	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Prednisolone—allergic rhinitis	0.00032	0.0205	CbGdCrCtD
Carfilzomib—PSMB2—HIV Infection—CD4—allergic rhinitis	0.00032	0.00276	CbGpPWpGaD
Carfilzomib—PSMB1—HIV Infection—CD4—allergic rhinitis	0.00032	0.00276	CbGpPWpGaD
Carfilzomib—PSMB5—HIV Infection—CD4—allergic rhinitis	0.00032	0.00276	CbGpPWpGaD
Carfilzomib—PSMB8—HIV Infection—CD4—allergic rhinitis	0.000315	0.00272	CbGpPWpGaD
Carfilzomib—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000315	0.00108	CcSEcCtD
Carfilzomib—Headache—Prednisolone—allergic rhinitis	0.000314	0.00107	CcSEcCtD
Carfilzomib—Vomiting—Hydrocortisone—allergic rhinitis	0.000312	0.00106	CcSEcCtD
Carfilzomib—Headache—Hydrocortisone—allergic rhinitis	0.000307	0.00105	CcSEcCtD
Carfilzomib—Dizziness—Triamcinolone—allergic rhinitis	0.000305	0.00104	CcSEcCtD
Carfilzomib—Dizziness—Methylprednisolone—allergic rhinitis	0.000305	0.00104	CcSEcCtD
Carfilzomib—Asthenia—Betamethasone—allergic rhinitis	0.000301	0.00103	CcSEcCtD
Carfilzomib—Asthenia—Dexamethasone—allergic rhinitis	0.000301	0.00103	CcSEcCtD
Carfilzomib—PSMB1—B Cell Activation—NFKB1—allergic rhinitis	0.000299	0.00258	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—NFKB1—allergic rhinitis	0.000299	0.00258	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—NFKB1—allergic rhinitis	0.000299	0.00258	CbGpPWpGaD
Carfilzomib—Nausea—Prednisolone—allergic rhinitis	0.000298	0.00102	CcSEcCtD
Carfilzomib—PSMB8—B Cell Activation—NFKB1—allergic rhinitis	0.000295	0.00254	CbGpPWpGaD
Carfilzomib—Vomiting—Triamcinolone—allergic rhinitis	0.000294	0.001	CcSEcCtD
Carfilzomib—Vomiting—Methylprednisolone—allergic rhinitis	0.000293	0.001	CcSEcCtD
Carfilzomib—Nausea—Hydrocortisone—allergic rhinitis	0.000291	0.000995	CcSEcCtD
Carfilzomib—Headache—Triamcinolone—allergic rhinitis	0.000289	0.000988	CcSEcCtD
Carfilzomib—Headache—Methylprednisolone—allergic rhinitis	0.000289	0.000986	CcSEcCtD
Carfilzomib—Diarrhoea—Dexamethasone—allergic rhinitis	0.000287	0.000979	CcSEcCtD
Carfilzomib—Diarrhoea—Betamethasone—allergic rhinitis	0.000287	0.000979	CcSEcCtD
Carfilzomib—Dizziness—Betamethasone—allergic rhinitis	0.000277	0.000946	CcSEcCtD
Carfilzomib—Dizziness—Dexamethasone—allergic rhinitis	0.000277	0.000946	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Hydrocortisone—allergic rhinitis	0.000276	0.0177	CbGdCrCtD
Carfilzomib—Nausea—Triamcinolone—allergic rhinitis	0.000274	0.000937	CcSEcCtD
Carfilzomib—Nausea—Methylprednisolone—allergic rhinitis	0.000274	0.000935	CcSEcCtD
Carfilzomib—PSMB10—Immune System—IL5—allergic rhinitis	0.00027	0.00233	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL5—allergic rhinitis	0.000268	0.00232	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000267	0.00231	CbGpPWpGaD
Carfilzomib—Vomiting—Betamethasone—allergic rhinitis	0.000266	0.00091	CcSEcCtD
Carfilzomib—Vomiting—Dexamethasone—allergic rhinitis	0.000266	0.00091	CcSEcCtD
Carfilzomib—PSMB9—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000266	0.0023	CbGpPWpGaD
Carfilzomib—Headache—Betamethasone—allergic rhinitis	0.000262	0.000896	CcSEcCtD
Carfilzomib—Headache—Dexamethasone—allergic rhinitis	0.000262	0.000896	CcSEcCtD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000261	0.00225	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000261	0.00225	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000261	0.00225	CbGpPWpGaD
Carfilzomib—PSMB8—Fluorometholone—Methylprednisolone—allergic rhinitis	0.00026	0.0167	CbGdCrCtD
Carfilzomib—PSMB5—Signaling Pathways—PTGDR2—allergic rhinitis	0.000258	0.00223	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PTGDR2—allergic rhinitis	0.000258	0.00223	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000258	0.00223	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCL11—allergic rhinitis	0.000258	0.00223	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000257	0.00222	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCL11—allergic rhinitis	0.000257	0.00222	CbGpPWpGaD
Carfilzomib—PSMB8—Fluorometholone—Dexamethasone—allergic rhinitis	0.000256	0.0164	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Betamethasone—allergic rhinitis	0.000256	0.0164	CbGdCrCtD
Carfilzomib—PSMB8—Signaling Pathways—PTGDR2—allergic rhinitis	0.000254	0.0022	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-G—allergic rhinitis	0.000254	0.00219	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-G—allergic rhinitis	0.000254	0.00219	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-G—allergic rhinitis	0.000254	0.00219	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ICAM1—allergic rhinitis	0.000251	0.00217	CbGpPWpGaD
Carfilzomib—PSMB8—Fluorometholone—Triamcinolone—allergic rhinitis	0.00025	0.016	CbGdCrCtD
Carfilzomib—PSMB9—Adaptive Immune System—ICAM1—allergic rhinitis	0.00025	0.00216	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-G—allergic rhinitis	0.00025	0.00216	CbGpPWpGaD
Carfilzomib—Nausea—Betamethasone—allergic rhinitis	0.000249	0.00085	CcSEcCtD
Carfilzomib—Nausea—Dexamethasone—allergic rhinitis	0.000249	0.00085	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisolone—allergic rhinitis	0.000232	0.0149	CbGdCrCtD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000221	0.00191	CbGpPWpGaD
Carfilzomib—PSMB8—Betamethasone—Flunisolide—allergic rhinitis	0.000217	0.0139	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Flunisolide—allergic rhinitis	0.000217	0.0139	CbGdCrCtD
Carfilzomib—PSMB8—Testosterone Propionate—Hydrocortisone—allergic rhinitis	0.000212	0.0136	CbGdCrCtD
Carfilzomib—PSMB10—Immune System—HLA-DQB1—allergic rhinitis	0.000209	0.0018	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-DQB1—allergic rhinitis	0.000208	0.00179	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL5—allergic rhinitis	0.000204	0.00176	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL5—allergic rhinitis	0.000204	0.00176	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL5—allergic rhinitis	0.000204	0.00176	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000203	0.00175	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000203	0.00175	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000203	0.00175	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL5—allergic rhinitis	0.000201	0.00174	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CYSLTR1—allergic rhinitis	0.0002	0.00172	CbGpPWpGaD
Carfilzomib—PSMB8—Diflorasone—Methylprednisolone—allergic rhinitis	0.000198	0.0127	CbGdCrCtD
Carfilzomib—PSMB2—Signaling Pathways—CCL11—allergic rhinitis	0.000196	0.00169	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL11—allergic rhinitis	0.000196	0.00169	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL11—allergic rhinitis	0.000196	0.00169	CbGpPWpGaD
Carfilzomib—PSMB8—Diflorasone—Betamethasone—allergic rhinitis	0.000195	0.0125	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Dexamethasone—allergic rhinitis	0.000195	0.0125	CbGdCrCtD
Carfilzomib—PSMB8—Signaling Pathways—CCL11—allergic rhinitis	0.000193	0.00166	CbGpPWpGaD
Carfilzomib—PSMB8—Diflorasone—Triamcinolone—allergic rhinitis	0.000191	0.0122	CbGdCrCtD
Carfilzomib—PSMB2—Adaptive Immune System—ICAM1—allergic rhinitis	0.00019	0.00164	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ICAM1—allergic rhinitis	0.00019	0.00164	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ICAM1—allergic rhinitis	0.00019	0.00164	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—SMAD3—allergic rhinitis	0.000189	0.00163	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—SMAD3—allergic rhinitis	0.000188	0.00162	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ICAM1—allergic rhinitis	0.000188	0.00162	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TAC1—allergic rhinitis	0.000188	0.00162	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TAC1—allergic rhinitis	0.000187	0.00161	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD4—allergic rhinitis	0.000185	0.00159	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD4—allergic rhinitis	0.000184	0.00159	CbGpPWpGaD
Carfilzomib—PSMB8—Diflorasone—Prednisolone—allergic rhinitis	0.000177	0.0113	CbGdCrCtD
Carfilzomib—PSMB10—Disease—SMAD3—allergic rhinitis	0.000175	0.00151	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—SMAD3—allergic rhinitis	0.000174	0.00151	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL5—allergic rhinitis	0.000174	0.00151	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL5—allergic rhinitis	0.000174	0.0015	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—NFKB1—allergic rhinitis	0.000159	0.00137	CbGpPWpGaD
Carfilzomib—PSMB8—Norethindrone—Hydrocortisone—allergic rhinitis	0.000159	0.0102	CbGdCrCtD
Carfilzomib—PSMB9—Adaptive Immune System—NFKB1—allergic rhinitis	0.000158	0.00137	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-DQB1—allergic rhinitis	0.000158	0.00137	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-DQB1—allergic rhinitis	0.000158	0.00137	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-DQB1—allergic rhinitis	0.000158	0.00137	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-DQB1—allergic rhinitis	0.000156	0.00135	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ICAM1—allergic rhinitis	0.000152	0.00132	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ICAM1—allergic rhinitis	0.000152	0.00131	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	0.000151	0.0013	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—SMAD3—allergic rhinitis	0.000143	0.00123	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—SMAD3—allergic rhinitis	0.000143	0.00123	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—SMAD3—allergic rhinitis	0.000143	0.00123	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TAC1—allergic rhinitis	0.000142	0.00123	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TAC1—allergic rhinitis	0.000142	0.00123	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TAC1—allergic rhinitis	0.000142	0.00123	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—SMAD3—allergic rhinitis	0.000141	0.00122	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TAC1—allergic rhinitis	0.00014	0.00121	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD4—allergic rhinitis	0.00014	0.00121	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD4—allergic rhinitis	0.00014	0.00121	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD4—allergic rhinitis	0.00014	0.00121	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD4—allergic rhinitis	0.000138	0.00119	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—SMAD3—allergic rhinitis	0.000133	0.00115	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SMAD3—allergic rhinitis	0.000133	0.00115	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SMAD3—allergic rhinitis	0.000133	0.00115	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL5—allergic rhinitis	0.000132	0.00114	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL5—allergic rhinitis	0.000132	0.00114	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL5—allergic rhinitis	0.000132	0.00114	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SMAD3—allergic rhinitis	0.000131	0.00113	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL5—allergic rhinitis	0.00013	0.00112	CbGpPWpGaD
Carfilzomib—PSMB8—Levonorgestrel—Hydrocortisone—allergic rhinitis	0.000127	0.00811	CbGdCrCtD
Carfilzomib—PSMB10—Signaling Pathways—SMAD3—allergic rhinitis	0.000123	0.00106	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SMAD3—allergic rhinitis	0.000122	0.00105	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—NFKB1—allergic rhinitis	0.000121	0.00104	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—NFKB1—allergic rhinitis	0.000121	0.00104	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—NFKB1—allergic rhinitis	0.000121	0.00104	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—NFKB1—allergic rhinitis	0.000119	0.00103	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ICAM1—allergic rhinitis	0.000115	0.000997	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ICAM1—allergic rhinitis	0.000115	0.000997	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ICAM1—allergic rhinitis	0.000115	0.000997	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ICAM1—allergic rhinitis	0.000114	0.000983	CbGpPWpGaD
Carfilzomib—PSMB8—Dexamethasone—Hydrocortisone—allergic rhinitis	0.000113	0.00722	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Hydrocortisone—allergic rhinitis	0.000113	0.00722	CbGdCrCtD
Carfilzomib—PSMB10—Immune System—CD4—allergic rhinitis	0.000112	0.000967	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—allergic rhinitis	0.000111	0.000962	CbGpPWpGaD
Carfilzomib—PSMB8—Betamethasone—Methylprednisolone—allergic rhinitis	0.000106	0.00681	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Methylprednisolone—allergic rhinitis	0.000106	0.00681	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Dexamethasone—allergic rhinitis	0.000105	0.00671	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Betamethasone—allergic rhinitis	0.000105	0.00671	CbGdCrCtD
Carfilzomib—PSMB10—Disease—CD4—allergic rhinitis	0.000103	0.000893	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—allergic rhinitis	0.000103	0.000888	CbGpPWpGaD
Carfilzomib—PSMB8—Betamethasone—Triamcinolone—allergic rhinitis	0.000102	0.00655	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Triamcinolone—allergic rhinitis	0.000102	0.00655	CbGdCrCtD
Carfilzomib—PSMB10—Immune System—NFKB1—allergic rhinitis	9.65e-05	0.000833	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—NFKB1—allergic rhinitis	9.6e-05	0.000829	CbGpPWpGaD
Carfilzomib—PSMB8—Dexamethasone—Prednisolone—allergic rhinitis	9.47e-05	0.00607	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Prednisolone—allergic rhinitis	9.47e-05	0.00607	CbGdCrCtD
Carfilzomib—PSMB1—Signaling Pathways—SMAD3—allergic rhinitis	9.3e-05	0.000803	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SMAD3—allergic rhinitis	9.3e-05	0.000803	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SMAD3—allergic rhinitis	9.3e-05	0.000803	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SMAD3—allergic rhinitis	9.17e-05	0.000792	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	8.94e-05	0.000772	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—allergic rhinitis	8.49e-05	0.000733	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—allergic rhinitis	8.49e-05	0.000733	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—allergic rhinitis	8.49e-05	0.000733	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—allergic rhinitis	8.37e-05	0.000722	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—allergic rhinitis	7.83e-05	0.000676	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—allergic rhinitis	7.83e-05	0.000676	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—allergic rhinitis	7.83e-05	0.000676	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—allergic rhinitis	7.72e-05	0.000667	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	7.45e-05	0.000643	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—TGFB1—allergic rhinitis	7.42e-05	0.000641	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—TGFB1—allergic rhinitis	7.38e-05	0.000637	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—NFKB1—allergic rhinitis	7.31e-05	0.000631	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—NFKB1—allergic rhinitis	7.31e-05	0.000631	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—NFKB1—allergic rhinitis	7.31e-05	0.000631	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—NFKB1—allergic rhinitis	7.21e-05	0.000622	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NFKB1—allergic rhinitis	6.24e-05	0.000538	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NFKB1—allergic rhinitis	6.21e-05	0.000536	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—allergic rhinitis	5.62e-05	0.000485	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—allergic rhinitis	5.62e-05	0.000485	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—allergic rhinitis	5.62e-05	0.000485	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—allergic rhinitis	5.54e-05	0.000479	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—allergic rhinitis	5.2e-05	0.000449	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—allergic rhinitis	5.17e-05	0.000446	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NFKB1—allergic rhinitis	4.73e-05	0.000408	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NFKB1—allergic rhinitis	4.73e-05	0.000408	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NFKB1—allergic rhinitis	4.73e-05	0.000408	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NFKB1—allergic rhinitis	4.66e-05	0.000402	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—allergic rhinitis	3.94e-05	0.00034	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—allergic rhinitis	3.94e-05	0.00034	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—allergic rhinitis	3.94e-05	0.00034	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—allergic rhinitis	3.88e-05	0.000335	CbGpPWpGaD
